225 related articles for article (PubMed ID: 37900585)
1. Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.
Gao L; Li MB; Li JY; Liu Y; Ren C; Feng DP
World J Gastroenterol; 2023 Oct; 29(38):5383-5394. PubMed ID: 37900585
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?
Karagiannakis DS
World J Gastroenterol; 2024 May; 30(20):2621-2623. PubMed ID: 38855160
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.
Jin YN; Zhang W
World J Gastroenterol; 2024 Apr; 30(16):2285-2286. PubMed ID: 38690019
[TBL] [Abstract][Full Text] [Related]
4. Hepatic recompensation according to Baveno VII criteria
Shaaban HE; Abdellatef A; Okasha HH
World J Gastroenterol; 2024 Mar; 30(12):1777-1779. PubMed ID: 38617737
[TBL] [Abstract][Full Text] [Related]
5. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
6. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
8. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
9. Advancing hepatic recompensation: Baveno VII criteria and therapeutic innovations in liver cirrhosis management.
Ridola L; Del Cioppo S
World J Gastroenterol; 2024 Jun; 30(23):2954-2958. PubMed ID: 38946869
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
Siramolpiwat S
World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
[TBL] [Abstract][Full Text] [Related]
11. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
Wang Q; Zhao H; Deng Y; Zheng H; Xiang H; Nan Y; Hu J; Meng Q; Xu X; Fang J; Xu J; Wang X; You H; Pan CQ; Xie W; Jia J
J Hepatol; 2022 Dec; 77(6):1564-1572. PubMed ID: 36038017
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
[TBL] [Abstract][Full Text] [Related]
14. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil.
Titton CM; Torikachvili M; Rêgo HMC; Medronha EF; Ziemiecki Junior E; Ribas C; Ceratti CG; Mattos AA; Tovo CV
Rev Assoc Med Bras (1992); 2023; 69(4):e20220944. PubMed ID: 37075438
[TBL] [Abstract][Full Text] [Related]
16. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
17. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
Horhat A; Bureau C; Thabut D; Rudler M
United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
[TBL] [Abstract][Full Text] [Related]
19. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.
Weichselbaum L; Lepida A; Marot A; Trépo E; Moreno C; Deltenre P
United European Gastroenterol J; 2022 Oct; 10(8):874-887. PubMed ID: 36217553
[TBL] [Abstract][Full Text] [Related]
20. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
Deipolyi AR; Kalva SP; Oklu R; Walker TG; Wicky S; Ganguli S
AJR Am J Roentgenol; 2014 Sep; 203(3):668-73. PubMed ID: 25148174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]